APM

Avidity Partners Management Portfolio holdings

AUM $442M
1-Year Est. Return 192.34%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+192.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$347M
AUM Growth
-$92.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
54
New
Increased
Reduced
Closed

Top Buys

1
+$9.29M
2
+$5.96M
3
+$5.89M
4
CNC icon
Centene
CNC
+$4.47M
5
RGEN icon
Repligen
RGEN
+$4.23M

Top Sells

1
+$42.6M
2
+$12.2M
3
+$11.6M
4
DHR icon
Danaher
DHR
+$8.29M
5
MDT icon
Medtronic
MDT
+$8.06M

Sector Composition

1 Healthcare 98.84%
2 Consumer Staples 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WAT icon
26
Waters Corp
WAT
$32.7B
$3.08M 0.89%
+8,100
ACAD icon
27
Acadia Pharmaceuticals
ACAD
$3.78B
$2.86M 0.82%
106,900
-37,100
GMAB icon
28
Genmab
GMAB
$16.5B
$2.83M 0.82%
92,000
-156,100
NTRA icon
29
Natera
NTRA
$28.2B
$2.7M 0.78%
11,800
-58,600
IMUX icon
30
Immunic
IMUX
$172M
$2.51M 0.72%
469,941
ACHC icon
31
Acadia Healthcare
ACHC
$2.46B
$2.4M 0.69%
+169,000
ITGR icon
32
Integer Holdings
ITGR
$3.05B
$2.34M 0.67%
+29,800
ELVN icon
33
Enliven Therapeutics
ELVN
$2.62B
$2.16M 0.62%
140,300
PVLA
34
Palvella Therapeutics
PVLA
$1.71B
$2.02M 0.58%
+19,300
HQY icon
35
HealthEquity
HQY
$6.95B
$1.55M 0.45%
16,900
-8,400
SCYX icon
36
SCYNEXIS
SCYX
$61.2M
$1.32M 0.38%
2,081,660
-1,268,868
IQV icon
37
IQVIA
IQV
$28.5B
$992K 0.29%
+4,400
KPTI icon
38
Karyopharm Therapeutics
KPTI
$201M
$990K 0.29%
134,566
CORT icon
39
Corcept Therapeutics
CORT
$6.26B
$766K 0.22%
+22,000
ABBV icon
40
AbbVie
ABBV
$372B
– –
-19,800
AKRO
41
DELISTED
Akero Therapeutics
AKRO
– –
-40,500
ARQT icon
42
Arcutis Biotherapeutics
ARQT
$2.7B
– –
-214,400
ARVN icon
43
Arvinas
ARVN
$608M
– –
-698,363
ASND icon
44
Ascendis Pharma A/S
ASND
$15.2B
– –
-14,500
BEAM icon
45
Beam Therapeutics
BEAM
$3.04B
– –
-112,000
BMY icon
46
Bristol-Myers Squibb
BMY
$116B
– –
-257,600
EXAS
47
DELISTED
Exact Sciences
EXAS
– –
-73,600
IMRX icon
48
Immuneering
IMRX
$333M
– –
-90,900
JNJ icon
49
Johnson & Johnson
JNJ
$556B
– –
-26,800
XENE icon
50
Xenon Pharmaceuticals
XENE
$5.41B
– –
-53,400
1
2
3